SHH · 600351.SS
Yabao Pharmaceutical Group Co., Ltd
CN¥7.18+CN¥0.08 (+1.13%)
Yabao Pharmaceutical Group Co., Ltd’s quoted price sits in the upper half of its reported 52-week range, 3.62% below the high.
Loading market information…
SHZ · 301580.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:16 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Aidite Qinhuangdao Technology Co Ltd’s quoted price sits in the lower half of its reported 52-week range, 57.23% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Aidite Qinhuangdao Technology Co Ltd’s forward annual dividend is CN¥0.46 per share, paid annual. The forward yield is 1.13% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
Aidite Qinhuangdao Technology Co Ltd’s next earnings report is currently expected on Oct 30, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Aidite Qinhuangdao Technology Co Ltd’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Aidite (Qinhuangdao) Technology Co., Ltd. is a key player in the research, development, production, and commercialization of advanced zirconia materials for dental applications. The company offers a comprehensive suite of dental solutions under its 'Cameo' brand. This extensive portfolio encompasses cutting-edge materials like Cameo 3D instant restorative zirconia and Cameo glass ceramics, alongside essential equipment. These include the Cameo intraoral scanner, the Cameo N4 and AV-D5 milling machines (with specialized systems for dry zirconia milling via the AV-D5 and wet glass ceramics milling via the N4), as well as Cameo fast sintering and glaze furnaces, providing a complete workflow for dental professionals. Established on March 15, 2007, by co-founders Hong Wen Li and Bin Li, the enterprise is headquartered in Qinhuangdao, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:31 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
CN¥7.18+CN¥0.08 (+1.13%)
Yabao Pharmaceutical Group Co., Ltd’s quoted price sits in the upper half of its reported 52-week range, 3.62% below the high.
CN¥11.55-CN¥0.45 (-3.75%)
Shenzhen Lifotronic Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 20.6% below the high.
CN¥9.33+CN¥0.09 (+0.97%)
Jiangxi Sanxin Medtec Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 13.54% below the high.
CN¥10.71-CN¥0.03 (-0.28%)
GuiZhou SanLi Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 38.66% below the high.
CN¥7.41+CN¥0.04 (+0.54%)
ZJAMP Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.48% below the high.
CN¥39.08+CN¥0.33 (+0.85%)
Nanjing Vishee Medical Technology Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 45.93% below the high.
CN¥8.30-CN¥0.07 (-0.84%)
Tibet Weixinkang Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 30.22% below the high.
CN¥9.18+CN¥0.01 (+0.11%)
Pulike Biological Engineering, Inc.’s quoted price sits in the lower half of its reported 52-week range, 37.04% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
